Hambleton Equine Clinic Limited 08227877 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true false 08227877 2024-04-01 2025-03-31 08227877 2025-03-31 08227877 core:ProvisionsDeferredTax 2025-03-31 08227877 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-03-31 08227877 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2025-03-31 08227877 core:CurrentFinancialInstruments 2025-03-31 08227877 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 08227877 core:Non-currentFinancialInstruments 2025-03-31 08227877 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 08227877 core:Goodwill 2025-03-31 08227877 core:BetweenTwoFiveYears 2025-03-31 08227877 core:WithinOneYear 2025-03-31 08227877 core:FurnitureFittingsToolsEquipment 2025-03-31 08227877 core:LandBuildings 2025-03-31 08227877 core:MotorVehicles 2025-03-31 08227877 bus:SmallEntities 2024-04-01 2025-03-31 08227877 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08227877 bus:FilletedAccounts 2024-04-01 2025-03-31 08227877 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 08227877 bus:RegisteredOffice 2024-04-01 2025-03-31 08227877 bus:Director1 2024-04-01 2025-03-31 08227877 bus:Director2 2024-04-01 2025-03-31 08227877 bus:Director3 2024-04-01 2025-03-31 08227877 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08227877 core:Goodwill 2024-04-01 2025-03-31 08227877 core:Buildings 2024-04-01 2025-03-31 08227877 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 08227877 core:LandBuildings 2024-04-01 2025-03-31 08227877 core:MotorCars 2024-04-01 2025-03-31 08227877 core:MotorVehicles 2024-04-01 2025-03-31 08227877 core:OfficeEquipment 2024-04-01 2025-03-31 08227877 core:PlantMachinery 2024-04-01 2025-03-31 08227877 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-04-01 2025-03-31 08227877 core:Subsidiary1 2024-04-01 2025-03-31 08227877 core:Subsidiary1 1 2024-04-01 2025-03-31 08227877 countries:EnglandWales 2024-04-01 2025-03-31 08227877 2024-03-31 08227877 core:Goodwill 2024-03-31 08227877 core:CostValuation 2024-03-31 08227877 core:FurnitureFittingsToolsEquipment 2024-03-31 08227877 core:LandBuildings 2024-03-31 08227877 core:MotorVehicles 2024-03-31 08227877 2023-04-01 2024-03-31 08227877 2024-03-31 08227877 core:ProvisionsDeferredTax 2024-03-31 08227877 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-03-31 08227877 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-03-31 08227877 core:CurrentFinancialInstruments 2024-03-31 08227877 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08227877 core:Non-currentFinancialInstruments 2024-03-31 08227877 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 08227877 core:Goodwill 2024-03-31 08227877 core:BetweenTwoFiveYears 2024-03-31 08227877 core:WithinOneYear 2024-03-31 08227877 core:FurnitureFittingsToolsEquipment 2024-03-31 08227877 core:LandBuildings 2024-03-31 08227877 core:MotorVehicles 2024-03-31 08227877 core:Subsidiary1 1 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 08227877

Prepared for the registrar
Hambleton Equine Clinic Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2025

Hambleton Equine Clinic Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 12

Hambleton Equine Clinic Limited

Company Information

Directors | C M Cramp A J Walters P Cramp

Registered office | The Paddock Stanley Grange Great Ayton North Yorkshire TS9 6QD

Accountants | Hazlewoods LLP Staverton Court Staverton Cheltenham GL51 0UX

Hambleton Equine Clinic Limited

(Registration number: 08227877)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | 23,692 | 25,447
Tangible assets | 5 | 959,341 | 820,822
Investments | 6 | 50 | 50
|  | 983,083 | 846,319
Current assets |  |  |
Stocks |  | 197,175 | 169,197
Debtors | 7 | 787,606 | 894,492
Cash at bank and in hand |  | 112,492 | 38,685
|  | 1,097,273 | 1,102,374
Creditors: Amounts falling due within one year | 8 | (512,891) | (396,295)
Net current assets |  | 584,382 | 706,079
Total assets less current liabilities |  | 1,567,465 | 1,552,398
Creditors: Amounts falling due after more than one year | 8 | (123,779) | (135,154)
Deferred tax liabilities | 9 | (182,147) | (145,606)
Net assets |  | 1,261,539 | 1,271,638
Capital and reserves |  |  |
Called up share capital |  | 50 | 50
Retained earnings |  | 1,261,489 | 1,271,588
Shareholders' funds |  | 1,261,539 | 1,271,638

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Hambleton Equine Clinic Limited

(Registration number: 08227877)
Balance Sheet as at 31 March 2025

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 5 November 2025 and signed on its behalf by:

C M Cramp
Director

A J Walters
Director

P Cramp
Director

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Paddock
Stanley Grange
Great Ayton
North Yorkshire
TS9 6QD

| 2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Leasehold Improvements | Nil
Equipment | 15% of written down value
Fixtures | 10% of written down value
Computer equipment | 33.33% of cost
Motor Vehicles | 25% of written down value

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Goodwill

Goodwill is amortised over its useful life, which shall not exceed five years if a reliable estimate of the useful life cannot be made.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.
Negative goodwill arising on an acquisition is recognised on the face of the balance sheet on the acquisition date and subsequently the excess up to the fair value of non-monetary assets acquired is recognised in profit or loss in the periods in which the non-monetary assets are recovered.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | Amortised over 20 years

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

| 3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

| 2025 No. | 2024 No.
Average number of employees | 53 | 52

| 4 | Intangible assets

| Goodwill £ | Total £
Cost
At 1 April 2024 | 35,100 | 35,100
At 31 March 2025 | 35,100 | 35,100
Amortisation
At 1 April 2024 | 9,653 | 9,653
Amortisation charge | 1,755 | 1,755
At 31 March 2025 | 11,408 | 11,408
Carrying amount
At 31 March 2025 | 23,692 | 23,692
At 31 March 2024 | 25,447 | 25,447

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 5 | Tangible assets

| Land and buildings £ | Furniture, fittings and equipment £ | Motor vehicles £ | Total £
Cost
At 1 April 2024 | 278,230 | 735,757 | 124,547 | 1,138,534
Additions | - | 235,098 | - | 235,098
At 31 March 2025 | 278,230 | 970,855 | 124,547 | 1,373,632
Depreciation
At 1 April 2024 | - | 275,519 | 42,193 | 317,712
Charge for the year | - | 75,991 | 20,588 | 96,579
At 31 March 2025 | - | 351,510 | 62,781 | 414,291
Carrying amount
At 31 March 2025 | 278,230 | 619,345 | 61,766 | 959,341
At 31 March 2024 | 278,230 | 460,238 | 82,354 | 820,822

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 6 | Investments

| 2025 £ | 2024 £
Investments in associates | 50 | 50

Associates | £
Cost
At 1 April 2024 | 50
Provision
Carrying amount
At 31 March 2025 | 50
At 31 March 2024 | 50

Details of undertakings

Details of the investments in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking |  | Holding | Proportion of voting rights and shares held
|  |  | 2025 | 2024
Subsidiary undertakings
Solway Equine Vets Limited |  |
Ordinary £1 shares
50%
50%

Subsidiary undertakings
Solway Equine Vets Limited The principal activity of Solway Equine Vets Limited is the provision of veterinary services.

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 7 | Debtors

| 2025 £ | 2024 £
Trade debtors | 623,072 | 780,540
Receivables from related parties | 112,518 | 83,894
Prepayments | 45,776 | 25,551
Other debtors | 6,240 | 4,507
| 787,606 | 894,492

| 8 | Creditors

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 10 | 81,212 | (25,467)
Trade creditors |  | 191,286 | 156,874
Taxation and social security |  | 215,071 | 250,115
Accruals and deferred income |  | 16,983 | 12,472
Other creditors |  | 8,339 | 2,301
|  | 512,891 | 396,295

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 10 | 123,779 | 135,154

| 9 | Deferred tax

Deferred tax assets and liabilities

2025 | Liability £
Difference between accumulated depreciation and amortisation and capital allowances | 182,147
| 182,147

2024 | Liability £
Difference between accumulated depreciation and amortisation and capital allowances | 145,606
| 145,606

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 10 | Loans and borrowings

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 46,000 | 30,000
Hire purchase contracts | 42,708 | 57,146
Other borrowings | (7,496) | (112,613)
| 81,212 | (25,467)

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 66,333 | 35,000
Hire purchase contracts | 57,446 | 100,154
| 123,779 | 135,154

Hambleton Equine Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 11 | Financial commitments

Operating leases

The total of future minimum lease payments is as follows:

| 2025 £ | 2024 £
Not later than one year | 90,000 | 90,000
Later than one year and not later than five years | 67,500 | 157,500
| 157,500 | 247,500

The amount of non-cancellable operating lease payments recognised as an expense during the year was £90,000 (2024 - £90,000).

| 12 | Related party transactions

Hambleton Equine Clinic Stokesly Limited

(A Walters, C Cramp and P Cramp are all directors of Hambleton Equine Clinic (Stokesley) Limited)
At the balance sheet date the amount due from Hambleton Equine Clinic Stokesly Limited was £55,994 (2024: £55,994). This amount is included in other debtors. No interest is charged and there are no fixed repayment terms.

Walters and Cramp Limited

(A Walters, C Cramp and P Cramp are all directors of Walters and Cramp Limited)
At the balance sheet date the amount due from Walters and Cramp Limited was £12,280 (2024: £12,280). This amount is included in other debtors. No interest is charged and there are no fixed repayment terms.
Solway Equine Vets Limited
(A Walters, C Cramp and P Cramp are all directors of Solway Equine Vets Limited)
At the balance sheet date the amount due from Solway Equine Vets Limited was £44,244 (2024: £15,620). This amount is included in other debtors. No interest is charged and there are no fixed repayment terms.

Summary of transactions with key management

Key management personnel are considered to be the directors of the company.
At the balance sheet date, the directors owed the company £7,496 (2024: £112,615). This amount is included in other borrowings. There are no fixed repayment terms and no interest is charged.